Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elanco Animal Health has the GF Score of 66, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Elanco Animal Health
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Elanco Animal Health (MEX:ELAN) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Elanco Animal Health GF Score Related Terms
MEX:ELAN vs ALKS, HIMS, NBIX: GF Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elanco Animal Health GF Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's GF Score distribution charts can be found below:
* The bar in red indicates where Elanco Animal Health's GF Score falls into.
Elanco Animal Health (MEX:ELAN) has a GF Score of 66 as of Jul. 14, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Elanco Animal Health and its competitors. This is near median its historical median of 62.00. Over the past decade, Elanco Animal Health's GF Score has ranged from 12.00 to 79.00.
Is Elanco Animal Health's GF Score too high?
Elanco Animal Health's current GF Score of 66 is near median its 10-year median of 62.00. Over the past 10 years, this metric has ranged from a low of 12.00 to a high of 79.00. Overall, Elanco Animal Health has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Elanco Animal Health's GF Score compare to ALKS and HIMS?
Elanco Animal Health's GF Score of 66 can be compared against companies in the Drug Manufacturers industry. Historically, Elanco Animal Health's own GF Score has ranged from 12.00 to 79.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Elanco Animal Health and its competitors. Elanco Animal Health's current GF Score is 66, which is near median its own 10-year median of 62.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elanco Animal Health stock overvalued right now?
Elanco Animal Health (MEX:ELAN) has a current GF Score of 66. The stock's GF Value™ is MXN243.25, compared to a current price of MXN392.00 — trading 61.2% above its estimated fair value. The current GF Score is 66, which is near median its 10-year median of 62.00. Elanco Animal Health's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Elanco Animal Health (MEX:ELAN), the current GF Score is 66 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elanco Animal Health (MEX:ELAN) Overvalued in 2026?
Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued.
The current stock price of MXN392.00 is trading 61.2% above its estimated GF Value™ of MXN243.25.
Key valuation signals for MEX:ELAN:
GF Score: 66 (near median its 10-year median of 62.00)
GF Value™: MXN243.25 vs. price of MXN392.00 (61.2% above fair value)
No single metric tells the full story. See the MEX:ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
66GF Score
Get the complete analysis for MEX:ELAN
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELAN has been successfully added to your 
